UBS Group’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $664M | Sell |
4,528,081
-193,663
| -4% | -$29.9M | 0.1% | 200 |
|
|
2025
Q4 | $731M | Buy |
4,721,744
+977,786
| +26% | +$146M | 0.12% | 156 |
|
|
2025
Q3 | $521M | Buy |
3,743,958
+470,812
| +14% | +$63.7M | 0.08% | 225 |
|
|
2025
Q2 | $441M | Sell |
3,273,146
-766,393
| -19% | -$103M | 0.08% | 248 |
|
|
2025
Q1 | $590M | Buy |
4,039,539
+564,005
| +16% | +$81.9M | 0.11% | 182 |
|
|
2024
Q4 | $478M | Sell |
3,475,534
-70,440
| -2% | -$10.3M | 0.09% | 201 |
|
|
2024
Q3 | $546M | Sell |
3,545,974
-348,438
| -9% | -$52.8M | 0.12% | 160 |
|
|
2024
Q2 | $568M | Buy |
3,894,412
+166,083
| +4% | +$23.8M | 0.14% | 131 |
|
|
2024
Q1 | $551M | Sell |
3,728,329
-186,696
| -5% | -$26.8M | 0.14% | 143 |
|
|
2023
Q4 | $534M | Buy |
3,915,025
+137,132
| +4% | +$17.8M | 0.16% | 126 |
|
|
2023
Q3 | $486M | Sell |
3,777,893
-18,311
| -0.5% | -$2.43M | 0.17% | 122 |
|
|
2023
Q2 | $504M | Sell |
3,796,204
-365,720
| -9% | -$48.2M | 0.17% | 126 |
|
|
2023
Q1 | $539M | Sell |
4,161,924
-232,833
| -5% | -$30.4M | 0.2% | 106 |
|
|
2022
Q4 | $597M | Sell |
4,394,757
-423,538
| -9% | -$56.1M | 0.22% | 92 |
|
|
2022
Q3 | $584M | Buy |
4,818,295
+1,166,243
| +32% | +$150M | 0.26% | 79 |
|
|
2022
Q2 | $468M | Buy |
3,652,052
+53,298
| +1% | +$6.99M | 0.19% | 111 |
|
|
2022
Q1 | $493M | Buy |
3,598,754
+575,158
| +19% | +$76.1M | 0.16% | 127 |
|
|
2021
Q4 | $426M | Sell |
3,023,596
-1,133,992
| -27% | -$151M | 0.12% | 168 |
|
|
2021
Q3 | $529M | Buy |
4,157,588
+550,488
| +15% | +$72.8M | 0.17% | 129 |
|
|
2021
Q2 | $454M | Sell |
3,607,100
-281,659
| -7% | -$34.5M | 0.15% | 140 |
|
|
2021
Q1 | $454M | Sell |
3,888,759
-1,587,718
| -29% | -$183M | 0.15% | 138 |
|
|
2020
Q4 | $621M | Buy |
5,476,477
+334,936
| +7% | +$36.6M | 0.21% | 110 |
|
|
2020
Q3 | $542M | Buy |
5,141,541
+748,794
| +17% | +$78.8M | 0.2% | 118 |
|
|
2020
Q2 | $440M | Buy |
4,392,747
+993,846
| +29% | +$98.1M | 0.19% | 125 |
|
|
2020
Q1 | $301M | Buy |
3,398,901
+131,791
| +4% | +$12.8M | 0.14% | 152 |
|
|
2019
Q4 | $333M | Sell |
3,267,110
-341,224
| -9% | -$32.8M | 0.12% | 178 |
|
|
2019
Q3 | $325M | Sell |
3,608,334
-545,798
| -13% | -$49.8M | 0.13% | 169 |
|
|
2019
Q2 | $385M | Sell |
4,154,132
-479,930
| -10% | -$43.1M | 0.15% | 148 |
|
|
2019
Q1 | $425M | Buy |
4,634,062
+1,057,970
| +30% | +$95.4M | 0.18% | 135 |
|
|
2018
Q4 | $309M | Sell |
3,576,092
-440,571
| -11% | -$39.9M | 0.14% | 161 |
|
|
2018
Q3 | $382M | Buy |
4,016,663
+190,323
| +5% | +$17.2M | 0.15% | 153 |
|
|
2018
Q2 | $319M | Sell |
3,826,340
-728,121
| -16% | -$60.3M | 0.14% | 172 |
|
|
2018
Q1 | $371M | Buy |
4,554,461
+58,097
| +1% | +$4.95M | 0.16% | 144 |
|
|
2017
Q4 | $372M | Sell |
4,496,364
-107,457
| -2% | -$8.86M | 0.15% | 157 |
|
|
2017
Q3 | $376M | Sell |
4,603,821
-250,111
| -5% | -$20.1M | 0.17% | 135 |
|
|
2017
Q2 | $385M | Buy |
4,853,932
+193,221
| +4% | +$14.7M | 0.2% | 127 |
|
|
2017
Q1 | $347M | Sell |
4,660,711
-1,099,407
| -19% | -$80.1M | 0.19% | 128 |
|
|
2016
Q4 | $397M | Sell |
5,760,118
-338,778
| -6% | -$23.5M | 0.22% | 109 |
|
|
2016
Q3 | $440M | Buy |
6,098,896
+1,188,427
| +24% | +$87.5M | 0.26% | 73 |
|
|
2016
Q2 | $352M | Buy |
4,910,469
+12,956
| +0.3% | +$913K | 0.22% | 104 |
|
|
2016
Q1 | $332M | Sell |
4,897,513
-1,721,874
| -26% | -$115M | 0.22% | 93 |
|
|
2015
Q4 | $477M | Sell |
6,619,387
-1,513,657
| -19% | -$107M | 0.31% | 62 |
|
|
2015
Q3 | $539M | Buy |
8,133,044
+2,048,944
| +34% | +$150M | 0.38% | 37 |
|
|
2015
Q2 | $453M | Sell |
6,084,100
-253,331
| -4% | -$18.8M | 0.3% | 61 |
|
|
2015
Q1 | $459M | Buy |
6,337,431
+2,617,052
| +70% | +$187M | 0.32% | 59 |
|
|
2014
Q4 | $254M | Buy |
+3,720,379
| New | +$249M | 0.18% | 135 |
|
Other funds holding XLV
HIIFS
UBS Group's XLV Position: Q1 2026 in Review
UBS Group reduced its State Street Health Care Select Sector SPDR ETF (XLV) stake by 4.1% in Q1 2026, selling an estimated $29.9M and leaving 4,528,081 shares worth $664M. The position accounts for 0.1% of the portfolio, ranked #200.
UBS Group first reported a position in XLV in Q4 2014 and has held it in 46 quarters since. The position peaked at $731M in Q4 2025. 1,802 funds tracked by Wall St. Rank hold XLV as of Q1 2026.
- UBS Group held 4,528,081 shares of State Street Health Care Select Sector SPDR ETF worth $664M as of Q1 2026.
- UBS Group sold 193,663 State Street Health Care Select Sector SPDR ETF shares in Q1 2026, an estimated $29.9M.
- State Street Health Care Select Sector SPDR ETF made up 0.1% of UBS Group's portfolio in Q1 2026, its #200 holding.
- UBS Group first reported a position in State Street Health Care Select Sector SPDR ETF in Q4 2014 and has held it in 46 quarters since.
- UBS Group's State Street Health Care Select Sector SPDR ETF position peaked at $731M in Q4 2025.
- 1,802 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q1 2026.
Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.